Identification and functional analysis of combined oxidative phosphorylation deficiency 28 gene mutation
10.3760/cma.j.cn112138-20211208-00875
- VernacularTitle:联合氧化磷酸化缺乏症28型基因突变的识别及功能分析
- Author:
Ping SHI
1
;
Yiping CHENG
;
Zongyue LI
;
Shuping WANG
;
Yingzhou SHI
;
Yiming JI
;
Li FANG
;
Jiajun ZHAO
;
Ling GAO
;
Chao XU
Author Information
1. 山东大学，济南 250021
- Keywords:
Acidosis, lactic;
Mutation;
Mitochondrial diseases;
Combined oxidative phosphorylation deficiency;
SLC25A26 gene mutation;
S-adenosyl methionine carrier;
Fu
- From:
Chinese Journal of Internal Medicine
2022;61(12):1324-1329
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To report a case of combined oxidative phosphorylation deficiency 28 (COXPD28) in China, identified the pathogenic mutation and explored the pathogenic mechanism preliminarily.Methods:The clinical characteristics of a patient with COXPD28 were retrospectively analyzed and the pathogenic mutations were identified by mitochondrial gene sequencing and whole exome sequencing. The wild-type and mutant plasmids of pathogenic genes were constructed, and effect of mutation on protein expression by quantitative real-time PCR (qPCR) and Western blot were evaluated. Statistical methods mainly used one-way ANOVA and LSD test.Results:A 21 year old female patient presented with lactic acid poisoning due to repeated chest distress and wheezing since childhood. The sequencing of the whole exon group gene found that solute carrier family 25 member 26 (SLC25A26) gene had a compound heterozygous mutation (c.34G>C, p.A12P; c.197C>A, p.A66E), which was the first report in China. In vitro function test showed that the expression levels of SLC25A26 mRNA and S-adenosylmethionine carrier (SAMC) protein in cells transfected with SLC25A26 mutant plasmid were significantly lower than those transfected with wild type plasmid. The p.A66E mutant plasmid reduced the expression level of SLC25A26 mRNA and SAMC protein to 6% and 26% of wild type plasmids respectively (both P<0.001), while p.A12P mutant plasmid decreased to 62% and 82% of wild type plasmids respectively ( P<0.001, P=0.044). When the double mutant (p.A66E+p.A12P) plasmids were co-transfected, the expression levels of SLC25A26 mRNA and SAMC protein decreased to 47% and 57% of the wild type plasmids, respectively ( P<0.001, P=0.001). Conclusion:The pathogenic mutation gene of this patient with COXPD28 is SLC25A26 gene mutation (p.A66E, p.A12P), which causes the decrease of SLC25A26 expression level, mitochondrial oxidative phosphorylation dysfunction, and induces COXPD28.
